|
|
 |
|

|
|
|
|
|
|
|
|
The following breakfast sessions will be held during the ASM:
Friday 26 October
|
Company: |

|
|
Session: |
Impact of Remote Access on Clinical Practice |
|
Time: |
7.00-8.00 |
|
Room: |
Skellerup |
|
Session overview: |
This breakfast session will focus on the emerging technologies enable remote access by clinicians to Patient Monitoring. The session will cover the following issues
- Technology overview
- Clinical Impact
- Changes in work flow - how does remote access empower the clinician
- Utility - how accessible and reliable is it
- Future directions
The session will involve a live feed and demonstration of remote access and encourage discussion from the members of the audience |
|
Session speakers: |
Dr Andrew Turner – Royal Hobart and Calvary Healthcare, Hobart, Tasmania
Mr Andrew Forrest – Critical Care Manager, GE Healthcare Australia and New Zealand |
|
RSVP |
andrew.forrest@ge.com |
|
|
Download flyer |
|
Company: |

|
|
Session: |
Surviving Sepsis:achieving the care bundles |
|
Time: |
7.00-8.00 |
|
Room: |
Works & Sigma |
|
Session overview: |
In 2002 the ESICM (European Society of Intensive Care Medicine), ISF (International Sepsis Forum) and SCCM (Society of Critical Care Medicine) established the SSC (Surviving Sepsis Campaign) with the aim to create an international collaborative effort to standardize the care of severe sepsis patients. In March 2004, the Guidelines for Management of Severe Sepsis and Septic Shock were published in the Critical Care Medicine Journal. The goal was to standardize the care of patients with severe sepsis and recent data has shown that the mortality of severe sepsis and septic shock can be reduced by implementing and following these recommendations. Dr Beale will present his experience in achieving the "sepsis bundles" at Guy's and
St Thomas
' Hospitals in
London
. |
|
Session speaker: |
Dr Richard Beale
Director or Perioperative and Critical Care and pain Management
Guy’s and St Thomas NHS Foundation Trust,
London
|
|
RSVP |
Tania Marczenko Ph:+61 2 9947 0158 or via email to tania.marczenko@philips.com |
|
|
Download flyer |
|
Company: |

|
|
Session: |
Husbandry of the ICU ecosystem |
|
Time: |
7.00-8.00 |
|
Room: |
Conference Room |
|
Session overview: |
In this session, we will discuss the basic principles of normal bacteriology as it pertains to the ICU, particularly (1) the biofilm and stringent state growth (2) the common gene pool and (3) managing the ecosystem. The argument is put for simple antibiotic regimens and regular ecological monitoring, and that other natural mechanisms such as bacteriophage and probiotic strategies should be considered. The management of this type of information will be discussed. |
|
Session speakers: |
Dr Jon Iredell, Associate Professor of Infectious Diseases |
|
RSVP |
QUINNEB@wyeth.com |
| |
Download flyer |
|
Company: |

|
|
Session: |
Closed Loop Ventilation Breakfast Symposium |
|
Time: |
7.00-8.00 |
|
Room: |
Community Trust Forum |
|
Session overview: |
HAMILTON MEDICAL is specialized in designing advanced ventilators for patients ranging from adults to neonates. The key developments are Adaptive Support Ventilation (ASV) Mode and the PV Tool, which are both invented by HAMILTON MEDICAL, as part of our mission to deliver superior technology.
Adaptive support ventilation (ASV) is today the most advanced fully closed loop mode of ventilation that provides the best breathing pattern in all lung conditions along with lung protection through to automatic weaning. The evidence to use ASV is based on reducing human error and to improve the overall quality of ventilation support.
Hamilton Medical is based in Switzerland and their products are acknowledged as being very user friendly with a very good cost of ownership. |
|
Session speakers: |
Marcus Schultz and Marc Wysocki |
|
RSVP |
Heather@intermed.co.nz |
|
|
Download flyer |
|
Company: |

|
|
Session: |
Oxygenation - Monitoring our precious resource |
|
Time: |
7.00-8.00 |
|
Room: |
Opus |
|
Session overview: |
This session consists of clinical cases presentations in both adults and paediatrics, outlining the use of continuous oximetry catheters. A discussion of the value of SVO2 and SCVO2 measurements in the clinical setting. What sort of patients benefit from monitoring supply and demand and a review of early goal directed therapies for these patients.
"We observed a lower mortality rate in patients with septic shock assigned to early goal directed-therapy (42.3 %) than those assigned to standard therapy (56.8%)" Rivers et al
Please visit www.edwards.com |
|
Session speakers: |
Dr Shay McGuiness, Intensivists CVICU Auckland Hospital
Dr Alastair McGeorge, Cardiac Anaethetist Auckland Hospital |
|
RSVP |
wendy_stacey@edwards.com |
|
|
Download flyer |
Saturday 27 October
|
Company: |

|
|
Session: |
Cuffed tubes in small children – changing the paradigma of paediatric airway management |
|
Time: |
7.30-8.30 |
|
Room: |
Works & Sigma |
|
Session overview: |
Until recently, in paediatric anaesthesia uncuffed endotracheal tubes were used routinely. Airway damage, mostly caused by oversized tubes and anatomical data led to the rule that only uncuffed tubes with a slight air leak must be used in children. Only when an uncuffed tube ideally matches the cricoid ring an acceptable connection between respirator and patient is obtained. The MICROCUFF* PET is a new paediatric cuffed tube with correct anatomical dimensions and an ultra-thin polyurethane cuff sealing at pressures <20 cm H2O. This tube allows precise ventilation and monitoring. The controlled pressure of the cuff is exerted below the cricoid ring. |
|
Session speakers: |
Andreas Ch. Gerber
University Children’s Hospital Zurich, Switzerland |
|
RSVP |
Claire Foureur on +61 2 9963 8664 or claire.foureur@kcc.com |
|
|
Download flyer |
|
Company: |

|
|
Session: |
The Next Step…NIV with Humidification |
|
Time: |
7.30-8.30 |
|
Room: |
Skellerup & Opus |
|
Session overview: |
The well documented risks associated with invasive ventilation has lead to a large increase in the use of non-invasive ventilation (NIV) therapies. The success of the use of NIV therapies is often compromised by inadequate humidification.
Dr Stefano Nava, and Dr Tony Williams will be discussing NIV and High Flow Nasal Oxygen Therapy (Optiflow™), the applications and effectiveness of optimal humidification with these therapies.
Providing optimal humidification to our intubated patients is standard of care – let’s take a look at the next step of extending this standard of care to our NIV patients |
|
Session speakers: |
Dr Stefano Nava and Dr Tony Williams |
|
RSVP |
barbara.baker@fphcare.co.nz |
|
|
Download flyer | |
|
|
|
|
 |
|